𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Unusual hepatitis B surface antigen variation in a child immunised against hepatitis B

✍ Scribed by Roznovsky, Ludek; Harrison, Tim J.; Fang, Zhong-Liao; Ling, Roger; Lochman, Ivo; Orsagova, Irena; Pliskova, Lenka


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
103 KB
Volume
61
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Perinatal transmission of and infection with hepatitis B (HBV) in early childhood are observed in a small proportion of the offspring of hepatitis B surface antigen (HBsAg)-positive mothers who are vaccinated against HBV immediately after giving birth. The children may be infected by wild-type HBV or by variants with amino acid substitutions in the "a" determinant of HBsAg, particularly at position 145 and, rarely, at positions 120, 126, 129, 131, 141, and 144. Four hundred and forty-six newborn infants of HBsAg-positive mothers in the northeastern part of the Czech Republic received combined active and passive immunisation against HBV. Only one child became an HBsAg carrier. This followed a mild, acute HBV illness in the beginning of the second year of his life. HBV DNA encoding the "a" determinant and surrounding region of HBsAg was sequenced after amplification from the plasma of the child and his mother. The child was infected with variants of HBsAg with substitutions at residues 137 and 139. The virus of the mother had changes at residues 120 and 121. HBV from both child and mother had an unusual substitution at residue 118 and seemed to be of the ayw subdeterminant.


πŸ“œ SIMILAR VOLUMES


Effect of variation in the common ?a? de
✍ Seddigh-Tonekaboni, Siamak; Waters, Jennifer A.; Jeffers, Sarah; Gehrke, Ralph; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 414 KB πŸ‘ 2 views

Antibody to the common "a" determinant of hepatitis B surface antigen (HBsAg) protects against infection with hepatitis B virus. A number of variant surface antigens with amino acid substitutions within the "a" determinant have been described in patients around the world. Both wild type and variant

A novel deletion mutant of hepatitis B v
✍ Weinberger, Klaus M.; Zoulek, Gert; Bauer, Tanja; BοΏ½hm, Stephan; Jilg, Wolfgang πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 194 KB πŸ‘ 2 views

HBsAg is the most important serological marker for acute or chronic hepatitis B. Nevertheless, there are reports of HBsAg-negative virus carriers, either with anti-HBc as the only marker for hepatitis B virus (HBV) infection or even positive for anti-HBs and anti-HBc. We report isolates from a patie

In vitro neutralization of hepatitis B v
✍ Ryu, Chun Jeih; Gripon, Philippe; Park, Heung Rok; Park, Sung Sup; Kim, Youn Kyu πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 358 KB πŸ‘ 2 views

In vitro HBV infection and neutralization were assayed using an anti-preS1 murine monoclonal antibody (1B3) and anti-preS2 (H69K) and anti-S (CS131A) murine-human chimeric antibodies. The 1B3 (IgG1) and H69K (IgG1) was constructed previously and the CS131A was constructed for this study by expressin

Bacterial expression of a human recombin
✍ Maeda, F.; Nagatsuka, Y.; Ihara, S.; Aotsuka, S.; Ono, Y.; Inoko, H.; Takekoshi, πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 278 KB πŸ‘ 1 views

The Fab fragment was cloned from the monoclonal cell line TAPC301-CL4, which was produced using the Epstein-Barr virus (EBV) transformation method. This cell line produces a human monoclonal antibody (CL4MAb) against the hepatitis B surface antigen (HBsAg). This MAb was shown to have hepatitis B vir